cholestyramine resin has been researched along with 1-deoxynojirimycin in 1 studies
Studies (cholestyramine resin) | Trials (cholestyramine resin) | Recent Studies (post-2010) (cholestyramine resin) | Studies (1-deoxynojirimycin) | Trials (1-deoxynojirimycin) | Recent Studies (post-2010) (1-deoxynojirimycin) |
---|---|---|---|---|---|
2,669 | 342 | 190 | 1,548 | 141 | 558 |
Protein | Taxonomy | cholestyramine resin (IC50) | 1-deoxynojirimycin (IC50) |
---|---|---|---|
Maltase-glucoamylase, intestinal | Homo sapiens (human) | 2.366 | |
Lysosomal acid glucosylceramidase | Homo sapiens (human) | 1 | |
Lysosomal alpha-glucosidase | Homo sapiens (human) | 1.015 | |
Sucrase-isomaltase, intestinal | Homo sapiens (human) | 2 | |
Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 1.3 | |
Sucrase-isomaltase, intestinal | Rattus norvegicus (Norway rat) | 0.3479 | |
Alpha-1D adrenergic receptor | Rattus norvegicus (Norway rat) | 1.3 | |
Protein-lysine 6-oxidase | Homo sapiens (human) | 1 | |
Glycogen debranching enzyme | Homo sapiens (human) | 10 | |
Glycogen debranching enzyme | Oryctolagus cuniculus (rabbit) | 0.19 | |
Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 1.3 | |
Alpha-amylase | Geobacillus stearothermophilus | 1.67 | |
Neutral alpha-glucosidase AB | Homo sapiens (human) | 1.3 | |
Lysosomal alpha-glucosidase | Rattus norvegicus (Norway rat) | 0.3125 | |
Putative alpha-glucosidase | Oryza sativa Japonica Group (Japanese rice) | 0.04 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Amioka, K; Furuta, Y; Wada, I | 1 |
1 other study(ies) available for cholestyramine resin and 1-deoxynojirimycin
Article | Year |
---|---|
[In-vitro study of the drug interactions between Miglitol, an alpha-glucosidase inhibitor, and adsorbents].
Topics: 1-Deoxynojirimycin; Adsorption; Carbohydrates; Carbon; Cation Exchange Resins; Cholestyramine Resin; Drug Interactions; Enzyme Inhibitors; Epichlorohydrin; Glycoside Hydrolase Inhibitors; Hydrogen-Ion Concentration; Hypoglycemic Agents; Imidazoles; Imino Pyranoses; In Vitro Techniques; Polyamines; Polystyrenes; Resins, Synthetic; Sevelamer | 2007 |